ANO1 inhibition subsequently leads to the reduction in phosphorylation of ERK1/2, AKT and v-src in breast cancer cells, HNSCCs, and esophageal squamous carcinoma cell lines [13]. This evidence concerns the gene ANO1 and breast cancer.